53 results
ARS
2023 FY
XFOR
X4 Pharmaceuticals Inc
29 Apr 24
Annual report to shareholders
4:58pm
the medical records of 44 healthcare organizations treating approximately 66 million patients. The analysis examined patients who had experienced at least two … to sell its products at a profit. Healthcare Reform Payors, whether domestic, foreign, governmental or private, are developing increasingly
424B3
84p7a sebpud3t2
20 Jun 23
Prospectus supplement
5:36pm
8-K
EX-99.1
ni17bl05jaqs5v3ja
16 May 23
X4 Pharmaceuticals Announces $65 Million Private Placement Priced At-the-Market
4:24pm
8-K
EX-10.1
moy 4p46aoewqqrxc0
16 May 23
X4 Pharmaceuticals Announces $65 Million Private Placement Priced At-the-Market
4:24pm
8-K
EX-10.2
ye4bnuh8
16 May 23
X4 Pharmaceuticals Announces $65 Million Private Placement Priced At-the-Market
4:24pm
8-K
EX-99.1
nnwa0 g3nri2c
29 Nov 22
X4 Pharmaceuticals Announces Positive Top-Line Results from 4WHIM Global, Pivotal Phase 3 Trial of Once-Daily, Oral Mavorixafor in WHIM Syndrome
4:05pm
8-K
EX-99.2
am6skl s1gjfs4ydy1t9
29 Nov 22
X4 Pharmaceuticals Announces Positive Top-Line Results from 4WHIM Global, Pivotal Phase 3 Trial of Once-Daily, Oral Mavorixafor in WHIM Syndrome
4:05pm